Industry
Drug Manufacturers - Specialty & Generic
PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Newsdesk
June 26, 2024 | 8:25 pm
Portfolio Pulse from Benzinga Newsdesk
June 26, 2024 | 3:47 pm
Portfolio Pulse from Benzinga Newsdesk
June 26, 2024 | 12:06 pm
Portfolio Pulse from Avi Kapoor
June 14, 2024 | 12:19 pm
Portfolio Pulse from Avi Kapoor
June 13, 2024 | 6:07 pm
Portfolio Pulse from Benzinga Newsdesk
May 31, 2024 | 8:18 pm
Portfolio Pulse from Benzinga Newsdesk
May 08, 2024 | 12:39 pm
Portfolio Pulse from Avi Kapoor
April 16, 2024 | 6:17 pm
Portfolio Pulse from Benzinga Newsdesk
April 16, 2024 | 12:26 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.